SUBOXONE 2 MG
NALOXONE (NALOXONE HYDROCHLORIDE) : 2 MG BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) : 8 MG · DIN 02502348 · INDIVIOR UK LIMITED
Health Canada status: MARKETED
What is SUBOXONE?
SUBOXONE 2 MG contains NALOXONE (NALOXONE HYDROCHLORIDE) : 2 MG BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) : 8 MG. It is listed in the Health Canada Drug Product Database under DIN 02502348, held by INDIVIOR UK LIMITED, supplied as FILM, SOLUBLE for SUBLINGUAL ; BUCCAL administration. Health Canada currently lists it as marketed, status dated 20-Jan-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02502348 |
|---|---|
| Brand name | SUBOXONE |
| Generic / active ingredient | NALOXONE (NALOXONE HYDROCHLORIDE) : 2 MG BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) : 8 MG |
| Manufacturer | INDIVIOR UK LIMITED |
| Strength | 2 MG |
| Dosage form | FILM, SOLUBLE |
| Route of administration | SUBLINGUAL ; BUCCAL |
| Schedule | NARCOTICS (CDSA I) |
| ATC code | N07BC51 BUPRENORPHINE, COMBINATIONS |
| AHFS class | 28:08.12 ; 28:10.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 20-Jan-2021 |
| Original market date | 2021-01-20 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N07BC51 BUPRENORPHINE, COMBINATIONS. 12 of 16 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PMS-BUPRENORPHINE-NALOXONE | 0.5 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02424851 |
| PMS-BUPRENORPHINE-NALOXONE | 8 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02424878 |
| SUBOXONE | 0.5 MG | FILM, SOLUBLE | INDIVIOR UK LIMITED | MARKETED | DIN 02502313 |
| SUBOXONE | 0.5 MG | TABLET | INDIVIOR UK LIMITED | MARKETED | DIN 02295695 |
| SUBOXONE | 1 MG | FILM, SOLUBLE | INDIVIOR UK LIMITED | MARKETED | DIN 02502321 |
| SUBOXONE | 12 MG | TABLET | INDIVIOR UK LIMITED | MARKETED | DIN 02468085 |
| SUBOXONE | 16 MG | TABLET | INDIVIOR UK LIMITED | MARKETED | DIN 02468093 |
| SUBOXONE | 3 MG | FILM, SOLUBLE | INDIVIOR UK LIMITED | MARKETED | DIN 02502356 |
| SUBOXONE | 8 MG | TABLET | INDIVIOR UK LIMITED | MARKETED | DIN 02295709 |
| TEVA-BUPRENORPHINE/NALOXONE | 0.5 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02453908 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.